APA (7th ed.) Citation

Y, Z., Y, L., S, Z., W, L., M, T., & B, L. Decoding ARF4 and EIF5B-Based Prognostic Signatures and Immune Landscape Following Insufficient Radiofrequency Ablation in Hepatocellular Carcinoma: Through Multi-Omics and Experimental Validation. Dove Medical Press.

Chicago Style (17th ed.) Citation

Y, Zhang, Lu Y, Zheng S, Luo W, Tan M, and Luo B. Decoding ARF4 and EIF5B-Based Prognostic Signatures and Immune Landscape Following Insufficient Radiofrequency Ablation in Hepatocellular Carcinoma: Through Multi-Omics and Experimental Validation. Dove Medical Press.

MLA (9th ed.) Citation

Y, Zhang, et al. Decoding ARF4 and EIF5B-Based Prognostic Signatures and Immune Landscape Following Insufficient Radiofrequency Ablation in Hepatocellular Carcinoma: Through Multi-Omics and Experimental Validation. Dove Medical Press.